80 related articles for article (PubMed ID: 14508526)
1. Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo.
Ribatti D; Guidolin D; Conconi MT; Nico B; Baiguera S; Parnigotto PP; Vacca A; Nussdorfer GG
Oncogene; 2003 Sep; 22(41):6458-61. PubMed ID: 14508526
[TBL] [Abstract][Full Text] [Related]
2. Synergistic inhibition of human neuroblastoma-related angiogenesis by vinblastine and rapamycin.
Marimpietri D; Nico B; Vacca A; Mangieri D; Catarsi P; Ponzoni M; Ribatti D
Oncogene; 2005 Oct; 24(45):6785-95. PubMed ID: 16007159
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin inhibits FGF-2-mediated angiogenesis in vitro and in vivo.
Conconi MT; Nico B; Guidolin D; Baiguera S; Spinazzi R; Rebuffat P; Malendowicz LK; Vacca A; Carraro G; Parnigotto PP; Nussdorfer GG; Ribatti D
Peptides; 2004 Dec; 25(12):2179-85. PubMed ID: 15572208
[TBL] [Abstract][Full Text] [Related]
4. Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis.
Oehler MK; Hague S; Rees MC; Bicknell R
Oncogene; 2002 Apr; 21(18):2815-21. PubMed ID: 11973640
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenesis is produced by nontoxic doses of vinblastine.
Vacca A; Iurlaro M; Ribatti D; Minischetti M; Nico B; Ria R; Pellegrino A; Dammacco F
Blood; 1999 Dec; 94(12):4143-55. PubMed ID: 10590059
[TBL] [Abstract][Full Text] [Related]
6. Dose effects of continuous vinblastine chemotherapy on mammalian angiogenesis mediated by VEGF-A.
Albertsson P; Lennernäs B; Norrby K
Acta Oncol; 2008; 47(2):293-300. PubMed ID: 18210302
[TBL] [Abstract][Full Text] [Related]
7. Novel function of ascorbic acid as an angiostatic factor.
Ashino H; Shimamura M; Nakajima H; Dombou M; Kawanaka S; Oikawa T; Iwaguchi T; Kawashima S
Angiogenesis; 2003; 6(4):259-69. PubMed ID: 15166494
[TBL] [Abstract][Full Text] [Related]
8. Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth.
Martínez A; Zudaire E; Portal-Núñez S; Guédez L; Libutti SK; Stetler-Stevenson WG; Cuttitta F
Cancer Res; 2004 Sep; 64(18):6489-94. PubMed ID: 15374959
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells.
Wang LL; Li JJ; Zheng ZB; Liu HY; Du GJ; Li S
Eur J Pharmacol; 2004 Oct; 502(1-2):1-10. PubMed ID: 15464084
[TBL] [Abstract][Full Text] [Related]
10. Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis.
Marimpietri D; Brignole C; Nico B; Pastorino F; Pezzolo A; Piccardi F; Cilli M; Di Paolo D; Pagnan G; Longo L; Perri P; Ribatti D; Ponzoni M
Clin Cancer Res; 2007 Jul; 13(13):3977-88. PubMed ID: 17606732
[TBL] [Abstract][Full Text] [Related]
11. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
12. An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells.
Mangieri D; Nico B; Coluccia AM; Vacca A; Ponzoni M; Ribatti D
Cancer Lett; 2009 May; 277(2):199-204. PubMed ID: 19150583
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis by Abeta peptides.
Paris D; Townsend K; Quadros A; Humphrey J; Sun J; Brem S; Wotoczek-Obadia M; DelleDonne A; Patel N; Obregon DF; Crescentini R; Abdullah L; Coppola D; Rojiani AM; Crawford F; Sebti SM; Mullan M
Angiogenesis; 2004; 7(1):75-85. PubMed ID: 15302999
[TBL] [Abstract][Full Text] [Related]
14. A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer.
Lyons JM; Anthony CT; Thomson JL; Woltering EA
Ann Surg Oncol; 2008 Dec; 15(12):3407-14. PubMed ID: 18795370
[TBL] [Abstract][Full Text] [Related]
15. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
Roccaro AM; Hideshima T; Raje N; Kumar S; Ishitsuka K; Yasui H; Shiraishi N; Ribatti D; Nico B; Vacca A; Dammacco F; Richardson PG; Anderson KC
Cancer Res; 2006 Jan; 66(1):184-91. PubMed ID: 16397231
[TBL] [Abstract][Full Text] [Related]
16. Beta amyloid angiogenic activity in vitro and in vivo.
Boscolo E; Folin M; Nico B; Grandi C; Mangieri D; Longo V; Scienza R; Zampieri P; Conconi MT; Parnigotto PP; Ribatti D
Int J Mol Med; 2007 Apr; 19(4):581-7. PubMed ID: 17334633
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of in vivo angiogenesis by N-beta-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine.
Nishikawa T; Akiyama N; Kunimasa K; Oikawa T; Ishizuka M; Tsujimoto M; Natori S
Eur J Pharmacol; 2006 Jun; 539(3):151-7. PubMed ID: 16725138
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic and anti-tumor apoptotic activities of SJ-8002, a new piperazine derivative.
Yi EY; Jeong EJ; Song HS; Lee MS; Kang DW; Joo JH; Kwon HS; Lee SH; Park SK; Chung SG; Cho EH; Kim YJ
Int J Oncol; 2004 Aug; 25(2):365-72. PubMed ID: 15254733
[TBL] [Abstract][Full Text] [Related]
19. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.
Chen MJ; Chiou PP; Lin P; Lin CM; Siri S; Peck K; Chen TT
J Cell Biochem; 2007 Aug; 101(5):1316-27. PubMed ID: 17286280
[TBL] [Abstract][Full Text] [Related]
20. In vivo inhibition of human hepatocellular carcinoma related angiogenesis by vinblastine and rapamycin.
Ribatti D; Nico B; Mangieri D; Longo V; Sansonno D; Vacca A; Dammacco F
Histol Histopathol; 2007 Mar; 22(3):285-9. PubMed ID: 17163402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]